Language selection

Search

Details for: SUMATRIPTAN DF

Company: SIVEM PHARMACEUTICALS ULC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02385570SUMATRIPTAN DFSUMATRIPTAN (SUMATRIPTAN SUCCINATE)50 MGTABLETORAL
02385589SUMATRIPTAN DFSUMATRIPTAN (SUMATRIPTAN SUCCINATE)100 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Consumer Information

This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.

What the medication is used for

SUMATRIPTAN DF Tablets are intended to relieve your migraine headache and other associated symptoms of a migraine attack. SUMATRIPTAN DF Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use SUMATRIPTAN DF Tablets only to treat an actual migraine headache attack.

What it does

Migraine headache is believed to be caused by a widening of the blood vessels in the head. SUMATRIPTAN DF narrows these vessels and relieves the symptoms of migraine headache.

When it should not be used

Do not use SUMATRIPTAN DF if :

  • you are allergic to sumatriptan succinate or to any of the ingredients in SUMATRIPTAN DF (See “What the nonmedicinal ingredients are:”).
  • you have a history, or any symptoms or signs of a heart condition
  • you have high blood pressure
  • you are taking or have recently taken (within 2 weeks) a monoamine oxidase inhibitor (MAOI)
  • you are taking or have recently taken (within 24 hours) an ergotamine-containing medication or its derivatives, or another triptan used to treat migraine
  • you have any degree of liver disease

SUMATRIPTAN DF Tablets should not be used for the treatment of other types of headaches that are different from migraine attacks.

What the medicinal ingredient is

Sumatriptan succinate

What the non-medicinal ingredients are

SUMATRIPTAN DF (25 mg, 50 mg and 100 mg Tablets):
colloidal silicon dioxide, lactose, magnesium stearate, microcrystalline cellulose and crospovidone The film-coating for the 25 mg and 50 mg tablets for SUMATRIPTAN DF consists of titanium dioxide, polydextrose, hydroxypropyl methylcellulose, triacetin, polyethylene glycol. The film-coating for the 100 mg tablet for SUMATRIPTAN DF consists of titanium dioxide, polydextrose, hydroxypropyl methylcellulose, triacetin, polyethylene glycol, synthetic red iron oxide.

What dosage form it comes in

SUMATRIPTAN DF is available as pink 100 mg, white 50 mg, or white 25 mg film-coated tablets in bottles of 50 and blister packs of 6, 24 & 100 Tablets.

Warnings and precautions

BEFORE you use SUMATRIPTAN DF talk to your doctor or pharmacist if:

  • you are pregnant, think you might be pregnant, you are trying to become pregnant, you are using inadequate contraception or you are breast-feeding.
  • you have any chest pain, heart disease, shortness of breath, or irregular heartbeats, you have had a heart attack, or you have angina.
  • you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or are you postmenopausal or a male over 40).
  • you have ever had to stop taking this or any other medication because of an allergy or other problems, or you are allergic to sulpha-containing drugs.
  • you are taking any medications, including migraine medications such as other triptans, 5-HT1 agonists or those containing ergotamine, dihydroergotamine, or methysergide.
  • you have ever experienced difficulty moving one side of your body when you have a headache.
  • you have ever had a stroke, transient ischemic attacks (TIAs ), or Raynaud’s Syndrome.
  • you are under 18 years of age
  • you are over 65 years of age.
  • you are taking any medication for depression (lithium, monoamine oxidase inhibitors or selective serotonin reuptake inhibitors (SSRIs), or serotonin noradrenaline reuptake inhibitors (SNRIs)
  • you had, or you have any disease of the liver or kidney.
  • you had, or you have epilepsy or seizures.
  • this headache is different from your usual migraine attacks.

SUMATRIPTAN DF Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use SUMATRIPTAN DF Tablets only to treat an actual migraine headache attack.

If you use SUMATRIPTAN DF Tablets too often, it may make your headaches worse. If this happens, your doctor may tell you to stop taking SUMATRIPTAN DF Tablets.

The Use of SUMATRIPTAN DF During Pregnancy
Do not use SUMATRIPTAN DF Tablets if you are pregnant, think you might be pregnant, are trying to become pregnant, or are not using adequate contraception, unless you have discussed this with your doctor.

Interactions with this medication

Do not use SUMATRIPTAN DF Tablets if you are taking or have recently taken a monoamine oxidase inhibitors (MAOI) in the last 2 weeks, or any migraine medications containing ergotamine, ergot derivatives (such as dihydroergotamine, or methysergide), or other triptans used to treat migraine within 24 hours.

You should tell your doctor if you are taking or have recently taken any other medications (prescription, nonprescription or natural/herbal), before you start taking SUMATRIPTAN DF Tablets, especially any antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and certain tricyclics.

Proper use of this medication

The label on the container of your medicine or the leaflet inside should tell you how often to take a dose and the amount you should take in each dose. If it does not or you are not sure, ask your doctor or pharmacist. DO NOT take more medicine or take your medicine more often than you are told.

Usual Dose

Adults: Take as directed by your doctor. If the first tablet does not relieve your headache, do not take further doses of sumatriptan for the same attack. You may take pain medication other than ergotamine-containing preparations for further pain relief. SUMATRIPTAN DF Tablets may be taken for subsequent attacks.

SUMATRIPTAN DF Tablets can be taken at any time during your migraine headache.

If your symptoms come back, and it has been two hours since your first tablet, you may take a second tablet.

Do not take more than 200 mg in any 24 hour period.

SUMATRIPTAN DF Tablets may be taken with or without food. The tablet should be swallowed whole with water. It should not be crushed, chewed or split.

Overdose

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
Side effects and what to do about them

Like all medications, SUMATRIPTAN DF Tablets can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Consult your doctor if you experience these or other side effects.

The most commonly reported side effects of SUMATRIPTAN DF Tablets are:

  • pain, pressure or tightness in any part of the body, including chest and throat
  • sensations of heaviness
  • unusual sensations including numbness, tingling, heat/burning or cold
  • flushing (redness of the face lasting for a short time)
  • feeling sick or vomiting
  • dizziness
  • drowsiness
  • tiredness
  • weakness
As drowsiness may occur as a result of using SUMATRIPTAN DF Tablets, do not drive or operate machinery until you are sure that you are not drowsy.

Other side effects include:
  • unusually slow or fast heartbeats, a feeling of irregular and/or forceful heartbeats
  • visual disturbances, usually temporary (scotoma, nystagmus, flickering, diplopia).
  • dystonia, (shaking, tremors or uncontrolled movements)
  • loss of normal colouration in the fingers and toes.
Tell your doctor of these symptoms at your next visit. Very rarely, some people have reported the following more serious side effects. For information on what to do if you experience these side effects, see the table at the end of this section.
  • pain or tightness in the chest or throat
  • loss of vision
  • shortness of breath; wheeziness; chest tightening; swelling of eyelids, face, or lips; or a skin rash, skin lumps
  • a seizure or fit
  • sudden and/or severe abdominal pain
  • persistent purple discolouration of hands or feet
If you feel unwell in any other way or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately.
Serious side effects, how often they happen and what to do about them
Symptom / effect Talk with your doctor, nurse, or pharmacist only if severe Talk with your doctor, nurse, or pharmacist in all cases Seek immediate medical emergency assistance
Common
Unusual sensations including numbness, tingling, feeling hot or cold; pain, heaviness or pressure in any part of the body including chest and throat.    
Very Rare
Symptoms of a heart attack [chest pain, sweating, shortness of breath].    
Unusually slow or fast heartbeats, or a feeling of irregular and/or forceful heartbeats.    
Allergic reactions [shortness of breath, sudden wheeziness, chest tightness, swelling of the eyelids, face or lips, lumpy skin rash or hives].    
Seizures [loss of consciousness with uncontrollable shaking (“fit”)].    
Lower abdominal pain and/or severe rectal bleeding.    
Raynaud’s phenomenon [persistent purple discolouration of hands or feet].    
Loss of vision.    

This is not a complete list of side effects. For any unexpected effects while taking SUMATRIPTAN DF, contact your doctor or pharmacist.

How to store

Keep your medicine in a safe place where children cannot reach it. It may be harmful to children.

Keep your tablets in a cool, dry place (15°C to 30°C).

If your medication has expired (the expiration date is printed on the treatment pack), throw it away as instructed.

If your doctor decides to stop your treatment, do not keep any leftover medicine unless your doctor tells you to. Throw away your medicine as instructed.

Reminder:
REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.

Reporting side effects

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:
    • Fax toll-free to 1-866-678-6789, or
    • Mail to:
      Canada Vigilance Program
      Health Canada
      Postal Locator 0701E
      Ottawa ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

More information

The name of your medicine is SUMATRIPTAN DF (sumatriptan succinate) Tablets. They can be obtained only by prescription from your doctor. The decision to use SUMATRIPTAN DF Tablets is one that you and your doctor should make jointly, taking into account your individual preferences and medical circumstances. If you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or you are postmenopausal or a male over 40), you should tell your doctor, who should evaluate you for heart disease in order to determine if SUMATRIPTAN DF Tablets are appropriate for you.

This document plus the full product monograph, prepared for health professionals can be found by contacting:
Sivem Pharmaceuticals ULC at:
1-855-788-3153

This leaflet was prepared by:

Sivem Pharmaceuticals ULC
4705 Dobrin Street
St. Laurent, Québec H4R 2P7

Last revised: July 8, 2015

Date modified: